CanCan Li

ORCID: 0000-0002-0656-3491
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ferroptosis and cancer prognosis
  • Renal cell carcinoma treatment
  • Mathematical Biology Tumor Growth

Second Affiliated Hospital of Zhengzhou University
2022

Background. With the highest mortality and metastasis rate, kidney renal clear cell carcinoma (KIRC) is one of most common urological malignant tumors not sensitive to chemotherapy radiotherapy. Immunotherapy, which proves be effective a big progression, such as PD-1/PD-L1 inhibitors, all KIRC patients. To predict prognosis immunotherapy response, novel immune checkpoint gene- (ICG-) related model essential in clinics. Methods. From public database-downloaded dataset, ICG-related for...

10.1155/2022/9010514 article EN Disease Markers 2022-12-30
Coming Soon ...